Biohope presents its innovative Immunobiogram® for kidney transplantation at the SAN Congr... 29/04/2024 Healthcare Access to innovation In vitro diagnostics Immunobiogram is an in vitro diagnostic device that allows physicians to optimize immunosuppressive therapy on an... Partners - Biohope
MATCH Biosystems, MIKROBIOMIK, and Oniria Therapeutics have been selected for the second e... 24/04/2024 Healthcare Access to innovation In vitro diagnostics Innovative drugs Personalized medicine The three companies, members of AseBio, work every day to improve treatments and patients' lives through rapid diagnosis... AseBio - Alira Health
Webinar: Preparing for IVDR Clinical Performance Studies Online Del 30/04/2024 17:00 to 30/04/2024 18:00 Healthcare Access to innovation In vitro diagnostics Personalized medicine The webinar will focu on the critical aspects of designing and conducting In Vitro Diagnostic (IVD) performance studies...
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and ... 24/03/2023 Healthcare Access to innovation In vitro diagnostics Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies Gene editing International The tool has many biotech applications Partners - Biotechnology Assets
Jornada; Regulación europea IVDR para tecnologías de diagnóstico In vitro CNIO, Melchor Fernández Almagro 3, 28029 Madrid y On-Line España Del 27/04/2023 09:00 to 27/04/2023 13:00 Healthcare Access to innovation In vitro diagnostics
NIVD, a deeptech startup in vitro nanodiagnostics, sets up at the Barcelona Science Park 27/09/2022 Healthcare In vitro diagnostics Personalized medicine Advanced therapies NIVD, a start-up that specialises in developing nanosensors for early diagnostics, has opened an R&D centre at the... Partners - Parc Científic de Barcelona
#NewMemberAseBio | "AseBio is the door to the networking with key relevant stakeholders in... 12/09/2022 Healthcare Access to innovation In vitro diagnostics Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company. AseBio - MiMARK diagnostics
MarketsandMarkets Single-Cell Analysis Conference UK/EU Edition London UK Del 06/10/2022 08:15 to 07/10/2022 17:10 Healthcare In vitro diagnostics Advanced therapies
Report | The incredible challenge of diagnosing a silent disease: Alzheimer's 21/09/2021 Healthcare In vitro diagnostics Personalized medicine To mark World Alzheimer's Day, we spoke to Marta Barrachina, founder and CEO of ADmit Therapeutics, one of our partners... AseBio - ADmit Therapeutics
